✦ LIBER ✦

CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance

✍ Scribed by Linenberger, M L

Book ID: 110056121
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 132 KB
Volume: 19
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403598

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemtuzumab ozogamicin, fludarabine, cyta

Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia

✍ Apostolia Tsimberidou; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Sr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Final report of the efficacy and safety

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

✍ Richard A. Larson; Eric L. Sievers; Edward A. Stadtmauer; Bob Löwenberg; Elihu H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 1 views